bluebird bio Inc (BLUE)
0.8998
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.904
0.00 (0.00%)
After-Hours: 20:00
bluebird bio Cash from Investing (Quarterly): 62.08M for Sept. 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 62.08M |
| June 30, 2023 | 6.945M |
| March 31, 2023 | 82.14M |
| December 31, 2022 | 103.24M |
| September 30, 2022 | 15.61M |
| June 30, 2022 | 61.68M |
| March 31, 2022 | 69.93M |
| December 31, 2021 | 60.93M |
| September 30, 2021 | 119.90M |
| June 30, 2021 | 60.37M |
| March 31, 2021 | 321.35M |
| December 31, 2020 | 148.82M |
| September 30, 2020 | -727.02M |
| June 30, 2020 | 269.28M |
| March 31, 2020 | 224.58M |
| December 31, 2019 | 183.25M |
| September 30, 2019 | 129.04M |
| June 30, 2019 | 232.43M |
| March 31, 2019 | -36.91M |
| December 31, 2018 | -421.09M |
| September 30, 2018 | 33.87M |
| June 30, 2018 | -27.49M |
| March 31, 2018 | -264.72M |
| December 31, 2017 | 27.59M |
| Date | Value |
|---|---|
| September 30, 2017 | -398.78M |
| June 30, 2017 | 59.02M |
| March 31, 2017 | -4.454M |
| December 31, 2016 | -132.56M |
| September 30, 2016 | 59.53M |
| June 30, 2016 | 75.69M |
| March 31, 2016 | 64.45M |
| December 31, 2015 | -221.17M |
| September 30, 2015 | -149.72M |
| June 30, 2015 | -7.993M |
| March 31, 2015 | -192.98M |
| December 31, 2014 | 27.60M |
| September 30, 2014 | -175.58M |
| June 30, 2014 | -6.69M |
| March 31, 2014 | -2.517M |
| December 31, 2013 | -5.29M |
| September 30, 2013 | -2.015M |
| June 30, 2013 | -1.706M |
| March 31, 2013 | -0.812M |
| December 31, 2012 | -0.356M |
| September 30, 2012 | -0.041M |
| June 30, 2012 | -0.179M |
| March 31, 2012 | 3.175M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-727.02M
Minimum
Sep 2020
321.35M
Maximum
Mar 2021
79.14M
Average
92.69M
Median
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | -886.50M |
| Novavax Inc | -9.078M |
| Motus GI Holdings Inc | 0.00 |
| Tivic Health Systems Inc | 0.00 |
| AIM ImmunoTech Inc | -0.214M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -61.85M |
| Cash from Financing (Quarterly) | -0.042M |
| Free Cash Flow | -286.43M |
| Free Cash Flow Per Share (Quarterly) | -0.5856 |
| Free Cash Flow to Equity (Quarterly) | -63.88M |
| Free Cash Flow to Firm (Quarterly) | -63.88M |
| Free Cash Flow Yield | -313.4% |